Table 3.
Components of effective coverage among those with 12-month major depressive disorder by country income level
| Coverage type | High-income countries (n = 1991) |
Low/middle-income countries (n = 1350) |
Significance between country income level (HICs vs LAMICs) | |||
|---|---|---|---|---|---|---|
| Among | Coverage type | % | (SE) | % | (SE) | F test |
| People with 12- month MDD (n = 3341) | Contact coverage | 52.0 | (1.5) | 26.5 | (1.3) | 145.5* |
| People with contact coverage (n = 1398) | Adequate pharmacotherapy | 27.6 | (1.7) | 22.3 | (3.3) | 1.7 |
| Any pharmacotherapy | 72.9 | (2.2) | 57.4 | (2.9) | 18.0* | |
| Adequate psychotherapy | 33.2 | (1.7) | 30.2 | (3.4) | 0.6 | |
| Any psychotherapy | 38.8 | (1.7) | 39.2 | (3.6) | 0.0 | |
| People with 12- month MDD (n = 3341) | Effective coverage | 16.3 | (0.9) | 6.0 | (0.9) | 41.5* |
HICs high-income countries; LAMICs low/middle-income countries; SE standard error; MDD major depressive disorder
*Significant at 0.05 level, two-sided test